NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis
The International Journal of Tuberculosis and Lung Disease, 04/09/2012Wang PY et al.
This meta–analysis showed that tuberculosis patients with slow acetylators had a higher risk of anti–tuberculosis drug–induced liver injury (ATLI) than other acetylators. Screening of patients for the N–acetyltransferase 2 (NAT2) genetic polymorphisms will be useful for the clinical prediction and prevention of ATLI.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.